Everolimus Eluting Cobalt Chromium Coronary Stent System (Drug Eluting Stent)

• L 605 cobalt-chromium stent platform with open and closed cell design

• Unique stent design and strut locking mechanism offers excellent radial strength and minimum recoil

• Completely biodegradable, biocompatible polymer (PLGA carrier) - Loading density of 1.2 μ/mm ²

• 6 μm - uniform coating thickness with precisely programmed release kinetics

• 95+5% of everolimus is released within 120 days

• Inhibits In-stent restenosis (ISR) and late stent thrombosis with adequate re-endothelization within 90 days

• Tappered design stent and delivery system

• Designed for utmost safety - Pristine displays one of the lowest entry profiles

• Hydrophilic coated stent delivery system